Genus plc (LON:GNS – Get Free Report) insider Jorgen Kokke sold 19,967 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of GBX 1,731 ($21.82), for a total transaction of £345,628.77 ($435,629.91).
Genus Price Performance
Shares of LON GNS traded up GBX 76.16 ($0.96) during mid-day trading on Friday, hitting GBX 1,826.16 ($23.02). 461,922 shares of the stock traded hands, compared to its average volume of 133,295. The company has a market cap of £1.20 billion, a PE ratio of 151.37, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. Genus plc has a twelve month low of GBX 1,424 ($17.95) and a twelve month high of GBX 2,155 ($27.16). The company has a debt-to-equity ratio of 53.12, a current ratio of 1.80 and a quick ratio of 1.08. The firm has a 50 day simple moving average of GBX 1,703.05 and a two-hundred day simple moving average of GBX 1,797.43.
Genus (LON:GNS – Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported GBX 39.80 ($0.50) EPS for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. As a group, equities research analysts forecast that Genus plc will post 70.9644323 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on GNS
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
See Also
- Five stocks we like better than Genus
- 3 REITs to Buy and Hold for the Long Term
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- Stock Sentiment Analysis: How it Works
- 5 Best Gold ETFs for March to Curb Recession Fears
- How to Profit From Growth Investing
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.